Connor, Clark & Lunn Investment Management Ltd.
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1596800
VANCOUVER, A1
Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,317,060
-$1,287,028 QoQ
Shares Held
215,206
-42.9% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 172 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. VNDA ranks #59 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in VNDA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,317,060 | 215,206 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,604,088 | 376,858 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,558,075 | 743,546 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,513,674 | 904,544 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,098,937 | 868,419 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,267,065 | 929,644 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,924,839 | 819,382 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,662,575 | 780,933 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $4,098,317 | 725,366 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,847,728 | 692,878 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,120,194 | 265,449 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,146,739 | 265,449 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,749,308 | 265,449 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,521,978 | 224,150 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,616,991 | 218,808 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,175,028 | 118,930 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $758,073 | 69,548 | Shares | Sole | 2022-08-05 | |
| 2021-06-30 ALXN | — | 9,842 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 ALXN | — | 12,550 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 ALXN | — | 11,954 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 ALXN | — | 8,742 | Shares | Sole | 2020-08-13 | |
| 2020-06-30 | $484,381 | 42,341 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 ALXN | — | 125,310 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||